Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort announced in April 2025, the program provides early-stage biotechnology pioneers with access to extensive scientific and commercial expertise, as well as a comprehensive ecosystem of discovery, development, and manufacturing capabilities, to expedite the develo.

Business Wire • Dec 11, 2025

T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform

BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles River Investment Management Solution (Charles River IMS). A Charles River client since 2002, T Rowe Price continues to deepen its engagement with Charles River Development to modernize front-office operations and streamline management of global equity, fixed income, and multi-asset portfolios. This lat.

Business Wire • Dec 4, 2025

Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript

Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 3, 2025

HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 1, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Charles River Laboratories International, Inc. (NYSE: CRL) breached their fiduciary duties to shareholders.

PRNewsWire • Dec 1, 2025

Charles River Laboratories to Present at Evercore Healthcare Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Evercore Healthcare Conference.

Business Wire • Dec 1, 2025

Madison Small Cap Fund Q3 2025 Portfolio Activity

The small cap team initiated a new investment position in Hexcel Corporation. Hexcel is a global leader in advanced composite materials. We initiated a position in Charles River Labs in Q3. CRL is a high-quality company in the drug discovery and development outsourcing space. Small cap exited Saia this quarter. The company has faced a challenging macroeconomic environment for LTL (less-than-truckload) pricing.

Seeking Alpha • Nov 21, 2025

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Charles River Laboratories International, Inc. ( CRL ) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST Company Participants Birgit Girshick - Corporate Executive VP & COO Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division All right. Good morning, everybody.

Seeking Alpha • Nov 18, 2025

SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers

STAMFORD, Conn.--(BUSINESS WIRE)--SOLVE, the leading provider of pre-trade data and predictive pricing for fixed income securities markets, today announced a new partnership with Charles River Development, a State Street company, to begin integrating SOLVE's fixed income and predictive pricing capabilities with the Charles River Investment Management Solution (Charles River IMS). The collaboration builds on SOLVE's mission to expand transparency across fixed income markets through advanced anal.

Business Wire • Nov 18, 2025

Charles River (CRL) International Revenue Performance Explored

Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Zacks Investment Research • Nov 17, 2025

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Jefferies Global Healthcare Conference.

Business Wire • Nov 17, 2025